Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview (original) (raw)
References
Kerr JFK, Wyllie AH, Currie AH: Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Brit J Cancer 26: 239–245, 1972 Google Scholar
Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytology 68: 251–306, 1980 Google Scholar
Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Path 32: 223–254, 1991 Google Scholar
Sarraf CE, Bowen ID: Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell and Tissue Kinetics 21: 45–49, 1988 Google Scholar
Moore JV: Death of cells and necrosis of tumours. In: Potten CS ed. Perspectives in mammalian cell death. Oxford: Oxford University Press, pp 295–325, 1987 Google Scholar
Searle J, Lawson TA, Abbott PJ, Harmon BV, Kerr JFR: An electron microscopy study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathology 116: 129–138, 1975 Google Scholar
Dyson JED, Simmons DM, Daniel J, McLaughlin JM, Quirke P, Bird CC: Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell and Tissue Kinetics 19: 311–324, 1986 Google Scholar
Eastman A: Activation of programmed cell death by anticancer agents: Cisplatin as a model system. Cancer Cells 2: 275–280, 1990 Google Scholar
Lennon SV, Martin SJ, Cotter TG: Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli. Biochem Soc Trans 18: 343, 1990 Google Scholar
Szende B, Zalatini A, Schally AW: Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proc Natl Acad Sci 86: 1643–1647, 1989 Google Scholar
Kyprianou N, English HF, Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748–3753, 1990 Google Scholar
Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following oestrogen ablation. Cancer Res 51: 162–166, 1991 Google Scholar
Martikainen P, Kyprianou N, Tucker RW, Isaacs JT: Programmed cell death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res 51: 4693–4700, 1991 Google Scholar
Kerr JFR, Searle J, Harmon BV, Bishop CJ: Apoptosis. In: Perspectives on mammalian cell death. CSPotten (ed), pp. 93–128, Oxford Science Publications: Oxford, 1987 Google Scholar
Arends MJ, Morris RJ, Wyllie AH: Apoptosis: the role of the endonuclease. Amer J Pathol 136: 593–608, 1990 Google Scholar
Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556, 1980b Google Scholar
Wyllie AH, Morris RG, Arends MJ: Nuclease activation in programmed cell death. In: Co-ordinated regulation of gene expression. Clayton RM, Truman DES (Eds), pp 33–44, Plenum Press, London, UK, 1986 Google Scholar
Duvall E, Wyllie AH, Morris RG: Macrophage recognition of cells undergoing programmed cell death. Immunology 56: 351–358, 1985 Google Scholar
Savill JS, Dransfield I, Hogg N, Haslett C: Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343: 170–173, 1990 Google Scholar
Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils inflammation: Programmed cell death in the neutrophil leads to recognition by macrophage. J Clin Investigation 83: 865–875, 1989 Google Scholar
Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, Piacentini M: Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett 245: 150–154, 1989 Google Scholar
Piacentini M, Autouori F, Dini L, Farraee MG, Ghibelli L, Piredda L, Fesus L. Tissue transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor stimulation. Cell Tissue Res 263: 227–235, 1991 Google Scholar
Fesus L, Davies PJA, Piacentini M: Molecular mechanisms in the program of cell death by apoptosis. Eur J Cell Biol 56: 170–177, 1991 Google Scholar
Wyllie AH, Morris RG: Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Amer J Pathology 109: 78–87, 1982 Google Scholar
McConkey DJ, Nicotera P, Hartzell P, Bellomo G, Wyllie AH, Orrenius S: Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic calcium concentration. Arch Biochem Biophys 269: 365–370, 1989a Google Scholar
Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Kramer PH: Monoclonal antibody-mediated tumour regression by induction of apoptosis. Science, 245: 301–305, 1989 Google Scholar
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Itase A, Yoshiyuki S, Negata S: The polypeptide encoded by the cDNA of human cell surface antigen fas can modulate apoptosis. Cell 66: 233–243, 1991 Google Scholar
Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T receptor complex induce cell death by apoptosis in immature thymic cultures. Nature, 337: 181–184, 1989 Google Scholar
Conroy LA, Jenkinson EJ, Owen JJT, Mitchell RH: The role of inosital lipid hydrolysis in the selection of immature thymocytes. Biochem Soc Trans 19: 90S, 1991
McConkey DJ, Hartzell P, Jondal M, Orrenius S: Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biolog Chem 264: 13399–13402, 1989 Google Scholar
McConkey DJ, Orrenius S, Jondal M: Cellular signalling in programmed cell death (apoptosis). Immunol Today 11: 120–121, 1989 Google Scholar
Kyprianou N, Alexander RB, Isaacs JT: Activation of programmed cell death by recombinant human tumour necrosis factor plus topoisomerase II-targeted drugs in L929 tumor cells. J Natl Cancer Inst 83: 346–350, 1991 Google Scholar
Laster SM, Wood JG, Gooding LR: Tumour necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141: 2629–2634, 1988 Google Scholar
Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142: 67–77, 1984 Google Scholar
Buttyan R, Zakeri Z, Lockshin R, Wolgemuth D: Cascade induction of c-fos, c-myc and heat shock protein 70K transcripts during regression of rat ventral prostate gland. Molec Endocrinol 11: 650–656, 1988 Google Scholar
Owens GP, Hahn W, Cohen JJ: Identification of mRNAs associated with programmed cell death in immature thymocytes. Molec Cell Biol 11: 4177–4188, 1991 Google Scholar
Monpetit ML, Lawless KR, Tenniswood M: Androgen-repressed messages in the rat ventral prostate. Prostate 8: 25–30, 1986 Google Scholar
Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed cell death. Molec Cell Biol 9: 3473–3481, 1989 Google Scholar
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992, in press)
Dive C, Wyllie AH: Apoptosis and cancer chemotherapy. In: JAHickman, TTTritton (eds) Frontiers in Pharmacology: Cancer Chemotherapy. Blackwell Scientific Oxford (1992, in press) Google Scholar
Hockenbery D, Nunez G, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336, 1990 Google Scholar
Nunez G, Landon L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: J Immunol 144: 3602, 1990 Google Scholar
Sentman CL, Shutter JR, Hockenbery D, Kanagawa D, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879–888, 1991 Google Scholar
Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889–899, 1991 Google Scholar
Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA: Rodent fibroblast tumours expressing myc and ras genes. Growth, metastasis and endogenous oncogene expression. Br J Cancer 56: 251–259, 1987 Google Scholar
Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343: 76–78, 1990 Google Scholar
Yonish-Rouach E, Resnitsky D, Lotem J, Sachs K, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345–347, 1991 Google Scholar
Kastan MB, Ohyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304–6311, 1991 Google Scholar
Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, McClennan ICM: The mechanisms of antigen-driven selection in germinal centres. Nature 342: 929–931, 1989 Google Scholar
Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961–6965, 1991 Google Scholar
Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ: bcl-2 maintains B cell memory. Nature 353: 71–73, 1991 Google Scholar
Cowan WM, Fawcett JW, O'Leary DDM, Stanfield BB: Regressive events in neurogenesis. Science 225: 1258–1265, 1984 Google Scholar
Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106: 829–844, 1988 Google Scholar
O'Connor TM, Wyttenbach CR: Cell death in the embryonic chick spinal cord. J Cell Biol 60: 448–459, 1974 Google Scholar
Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science 248: 378–381, 1990 Google Scholar
Ijiri K, Potten CS: Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 55: 113–123, 1987 Google Scholar
Going JJ, Anderson TJ, Wyllie AH: Ras p21 in breast tissue: association with pathology and cellular localisation. Br J Cancer 65: 45–50, 1992 Google Scholar
Williams ARW, Piris J, Spandidos DA, Wyllie AH: Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer 52: 687–693, 1985 Google Scholar
Gallick GE, Kurzrock R, Koetzer WS, Arlingham RB, Gutterman JU: Expression of p21 ras in fresh primary and metastatic human colorectal tumours. Proc Natl Acad Sci USA 82: 1795–0000, 1985 Google Scholar
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AL, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal tumor development. New Engl J Med 319: 525–532, 1988 Google Scholar
Clark HM, Jones DB, Wright DH: Cytogenetic and molecular studies of t(14; 18) in nodal and extranodal B-cell lymphoma. J Pathol 166: 129–137, 1992 Google Scholar
Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612–614, 1991 Google Scholar
Henderson S, Rowe M, Gregory CD, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson AB: Induction of bcl-2 expression by Epstein Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107–1115, 1991 Google Scholar
Levine AJ, Momard J, Finlay CA: The p53 tumour suppressor gene. Nature 351: 453–456, 1991 Google Scholar